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Interaction of smooth muscle caldesmon with cahnodulin, troponin C, S-100 protein and 67 kDa calcimedin was analyzed. Native gel electrophoresis 
and crosslinking revealed the complex formation between caldesmon and three EF-hand Ca-binding proteins, whereas calcimedin did not interact 
with caldesmon. In the presence of Ca”, calcimedin binds to actin-tropomyosin without affecting the interaction of caldesmon with this complex. 
Although calcimedin reversed the inhibitory action of caldesmon on the actomyosin ATPase activity at a lower concentration than three other 
Ca-binding proteins, this effect only slightly depends on Ca*+ and was observed at the concentration of calcimedm comparable to that of actin. 
It is concluded that calcimedin itself cannot be responsible for Ca-dependent regulation of caldesmon functioning, but actin bundling induced by 
calcimedin (or by other actin binding proteins) decreases the inhibitory action of caldesmon on the actomyosin ATPase activity. 
Caldesmon; Calcimedin; Calmodulin; Troponin C; S-100 
1. INTRODUCTION 
Caldesmon is an actin- and calmodulin-binding pro- 
tein playing an important structural and regulatory role 
in smooth muscles and certain non-muscle cells [1,2]. 
Caldesmon inhibits the ATPase activity of actomyosin 
and this inhibition is reversed only after addition of a 
large excess of Ca-saturated calmodulin [1,3]. Therefore 
it was supposed that cahnodulin mimics the effect of 
another much more effective Ca-binding protein which 
regulates caldesmon activity [3]. A partially purified 
fraction of Ca-binding proteins containing calmodulin, 
S-100 protein and calcimedin was more potent than 
isolated calmodulin in reversal of caldesmon induced 
inhibition of the actomyosin ATPase activity [3]. S-100 
protein [4-6] and caltropin [7] interact with caldesmon 
and reverse its inhibitory action on ATPase of acto- 
myosin. At the same time, in the case of smooth muscle 
actin, the effectivity of S-100 protein does not differ 
significantly from that of calmodulin [6]. Therefore the 
search for another Ca-binding protein involved in the 
regulation of caldesmon action was continued [8]. Since 
calcimedin was one of the constituents of the protein 
mixture effectively reversing caldesmon inhibition [3] it 
was desirable to analyze the effect of 67 kDa Ca- 
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phopholipid binding protein (calcimedin) on caldesmon 
functioning. 
2. MATERIALS AND METHODS 
Caldesmon and tropomyosin were isolated from duck gizzard by 
earlier described methods [9]. Actin and myosin were prepared from 
rabbit skeletal muscles [lO,li]. Cahnodulin and S-100 protein were 
obtained from bovine brain [12,13] and troponin C from rabbit skele- 
tal muscle [14]. 67 kDa calcimedin was purified from duck gizzard 
according to Kobayashi and Tashiia [15] with slight modifications. 
The interaction of Ca-binding proteins with caldesmon was meas- 
ured either by the method of native gel electrophoresis [4] or by using 
the cross-linking technique. Zero-length crosslinking was performed 
according to Grabarek and Gergely [16]. Ca-binding proteins (about 
0.3 m&ml) in 0.1 M MES @H 6.0), 100 mM NaCl, 0.1 mM CaCl, were 
mixed with EDC and NHS @al concentrations 2and 5 mM, respec- 
tively) and incubated for 15 min at 25°C. Reaction was quenched by 
mercaptoethanol (20 mM) and caldesmon (final concentration 0.3- 
0.6mg/ml) was added to the incubation mixture. After 3&60 min 
incubation at 25°C reaction was stopped by addition of SDS-contain- 
ing sample buffer and the protein composition was analyzed by 7-15% 
gradient polyacrylamide gel electrophoresis in the presence of SDS 
[ 11. Alternatively, caldesmon was activated by EDC and NHS by the 
same procedure and mixed with Ca-binding proteins. The mixture of 
caldesmon (0.6 mg/ml) and Ca-binding proteins (0.61 mg/ml) in 
50 mM MOPS pH 8.0, containing 0.1 mM CaCl, was also subjected 
to crosslinking by 1 mM DFDNB. After incubation for 30 min at 30°C 
the reaction was stopped either by addition of glycine (up to 70 mM) 
or mercaptoethanol(50 mM). The protein composition was analyzed 
by SDS-gel electrophoresis. 
The interaction of calcimedin with phospholipids and actin-tro- 
pomyosin or actin-tropomyosin-caldesmon complex was analyzed by 
ultracentrifugation. The mixture of azolectin (1.1 mg/ml) and calci- 
medin (0.3 mg/ml) in buffer A (10 mM Tris-HCl, pH 7.5, 0.5 mM 
mercaptoethanol, 0.1 mM PMSF) was ultracentrifuged for 1 h at 
116,000 x g and the protein composition of supematant and pellet was 
analyzed by SDS-gel electrophoresis. The mixture of actin (4pM) and 
tropomyosin (0.8 PM) in buffer B (10 mM Tris-HCl pH 8.0, 100 mM 
NaCl, 2 mM MgCl,, 1 mM ATP and 1 mM mercaptoethanol) was 
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titrated with calcimedin (final concentration l-10 PM) and after a 
15 min incubation at room temperature, ultracentrifuged at 
A 
130,000 x g for 40 min. Competition of calcimedin and caldesmon for 12 3 4 5 6 7 8 91011 
binding to actin-tropomyosin was analyzed by titrating the mixture of 
actin, tropomyosin and caldesmon by calcimedin or by titrating the 
mixture of actin, tropomyosin and calcimedin with caldesmon. After 
ultracentrifugation, the protein composition of the pellet and supema- 
tant was determined by quantitative scanning of Coomassie brilliant 
blue stained polyacrylamide gels [18]. 
The ability of Ca-binding proteins to detach caldesmon from the 
actin-tropomyosin complex was analyzed by ultracentrifugation. The 
mixture of actin (5 PM), tropomyosin (0.8 PM) and caldesmon 
(0.5 PM) in the buffer containing 15 mM imidazole (PH 7.0), 50 mM 
NaCl, 5 mM MgCl,, 0.2 mM CaCl,, 2 mM ATP and 2 mM mercap- 
toethanol was titrated by different Ca-binding proteins (final concen- 
tration l-7 PM). After ultracentrifugation the content of caldesmon 
in the supematant and pellet was determined by SDS-gel electrophore- 
sis. 
The ATPase activity of actomyosin was determined in the buffer 
containing 15 mM imidazole (pH 7.0), 5 mM MgCl,, 0.3 mM mercap- 
toethanol, 0.1 mM CaCl, and 2 mM ATP. The incubation mixture 
contained 1 PM actin, 0.2 PM tropomyosin and 0.3-0.4 PM myosin. 
Under these conditions the ATPase activity measured at 30°C by 
inorganic phosphate liberation [19] was equal to 300 nmol PJminlmg B 
of myosin. Addition of caldesmon (0.4 PM) induced 60-70% inhibi- 
tion of actomyosin ATPase. The inhibition induced by caldesmon was 
123456 
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reversed by different Ca-binding proteins (l-8 ,uM) which were added 
to the reconstructed actomyosin. Protein concentration was deter- 
mined either by molar extinction coefficients published in the litera- 
ture or by the method of Spector [20] using bovine serum albumin as 
a standard. 
3. RESULTS 
Slightly modified procedure of Kobayashi and 
Tashima [15] was used for purification of 67 kDa calci- 
medin from duck gizzard. The complex of calcimedins 
with membranes and cytoskeleton which was formed in 
the presence of Ca” was recovered after ultracentrifu- 
gation and calcimedin enriched fraction was extracted 
with EGTA. The thus obtained extract contained fil- 
amin, actin, tropomyosin and 67 and 32-34 kDa calci- 
medins. Further purification was achieved by ion-ex- 
change chromatography on DEAE-Toyopearl where 
calcimedins were eluted at 0.1-O. 15 M NaCl immedi- 
ately after filamin. Final purification and separation of 
67 and 32-34 kDa calcimedins was performed on the 
Ultrogel AcA 44 column. The yield of 67 kDa calci- 
medin was equal to 3-3.5 mg from 100 mg of duck 
gizzard and was slightly higher than that reported in the 
literature. In the presence (but not in the absence) of 
Ca2+, 67 kDa calcimedin interacted and was coprecipi- 
tated with azolectin (mixture of soybean phospholip- 
ids). This agrees well with the data of Kobayashi and 
Tashima [ 151. In the presence of Ca2+ 67 kDa calcimedin 
interacts with actin-tropomyosin complex. The half- 
maximal binding was observed at 4-6 ,uM calcimedin 
and saturation was achieved when about 0.5 mol of 
calcimedin were bound per mol of actin. Thus, all prop- 
erties of 67 kDa duck gizzard protein were similar to 
those of 67 kDa calcimedin isolated from chicken giz- 
zard. 
Fig. 1. Crosslinking of caldesmon with different Ca-binding proteins 
(A) Zerolength cross-linking of caldesmon with calmodulin (2-4). 
troponin C (5-7) and S-100 protein (8-10). 1 and 11, isolated cal- 
desmon; 2, 5 and 8, isolated Ca-binding proteins; 3, 6 and 9, Ca- 
binding proteins after activation with NHS and EDC; 4, 7 and 10, 
mixture of caldesmon with activated Ca-binding proteins after 
crosslinking. (B) Zero-length cross-linking of caldesmon and calci- 
medin. 1, isolated caldesmon; 2, caldesmon activated by EDC and 
NHS; 3, the mixture of calcimedin with activated calcimedin; 4, iso- 
lated calcimedin; 5, calcimedin activated by EDC and NHS; 6, the 
mixture of caldesmon with activated calcimedin. 
The interaction of different Ca-binding proteins with 
caldesmon was analyzed by two different methods. As 
described earlier [4] under nondenaturating conditions, 
the complex of caldesmon with calmodulin, troponin C 
or S-100 protein has higher electrophoretic mobility 
than isolated caldesmon. Although the complex of cal- 
desmon with the three above mentioned proteins was 
easily detected we failed to observe any complex forma- 
tion between caldesmon and calcimedin. 
We also used the method of zero-length crosslinking 
for analyzing the interaction of caldesmon with Ca- 
binding proteins. The data of Fig. 1A indicate that after 
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activation with EDC and NHS ~~~~in and tro- 
ponin C can be crosslinked to caldesmon in the presence 
of Ca2+. An earlier and similar method was successfully 
used for analysis of interaction of cahnodulin and its 
peptide with caldesmon [21]. We were unable to 
crosslink activated S-100 protein or activated calci- 
medin to caldesmon (Fig, 1). The same negative results 
were obtained when activated caldesmon was mixed 
with non-activated calcimedin (Fig. IB) or S-100 pro- 
tein. Using a short rigid bifunctional reagent DFDNB 
we crosslinked cahnodulin and troponin C with cal- 
desmon. At the same time we failed to detect crosslink- 
ing products when caldesmon was mixed with S-100 
protein or calcimedin. 
Both caldesmon and calcimedin interact with actin- 
tropomyosin complex, therefore it seems reasonable to 
analyze whether these proteins can compete for actin 
0.2 F”-Jo.* 
0.1 
2 4 
Calcimedin added pM 
0.1 
0.04 
0.02 
2 
Caldesmon added 
Fig. 2. (A) Effect of calcimedin on caldesmon binding to actin-tro- 
pomyosin. 14 PM actin and 7 PM tropomyosin containing 1 ,uM 
caldesmon were titrated with calcimedin and the protein composition 
of the pellet obtained after ultr~n~gation was analyzed by SDS- 
gel ehxtrophoresis. (B) Effect of caldesmon on the binding of calci- 
medin to actin-tropomyosin. 14 PM actin and 7 PM tropomyosin 
containing 1 PM calcimedin were titrated with caldesmon and proteins 
bound to actin were determined after ultracentrifugation. 
2 4 6 
[ Co binding protein 1 
Fig. 3. Effixt of Ca-binding proteins on the ATPase activity of skeletal 
muscle actomyosin inhibited by caldesmon. Final con~nt~tion of 
proteins was: actin, 1 fiM; myosin, 0.4 #M, tropomyosin, 0.14 FM, 
caldesmon, 0.4 PM. 60% inhibition of actomyosin ATPase activity 
induced by caldesmon was reversed by addition of calcimedin (I), 
S-100 protein (2), troponin C (3) and calmodulin (4). 
binding. The data of Fig. 2A indicate that binding of up 
to 0.2 mol of calcimedin per mol of actin does not 
decrease the quantity of caldesmon bound to actin. On 
the contrary when the actin-tropomyosin-calcimedin 
complex was titrated by caldesmon we observed more 
than two-fold decrease in calcimedin content (Fig. 2B). 
Thus, caldesmon displaced calcimedin from its complex 
with actin. Continuing these experiments we analyzed 
the ability of different Ca-binding proteins to detach 
caldesmon from actin-tropomyosin. Under the condi- 
tions used (5 yM actin, 0.8 PM tropomyosin and 0.5 
PM caldesmon), the ratio of caldesmon remaining free 
and bound to actin was equal to 1. Addition of 5 PM 
of calcimedin did not change this ratio, whereas addi- 
tion of 6 PM calmodulin, S-100 protein or troponin C 
increased this value up to 1.7-2.5. This means that in 
the presence of a large excess of EF-hand Ca-binding 
proteins caldesmon was detached from actin laments. 
In the final stage of the investigation we analyzed the 
ability of different Ca-binding proteins to reverse cal- 
desmon-induced inhibition of the actomyosin ATPase 
activity. As shown in Fig. 3 addition of S-100 protein, 
calmodulin or troponin C reversed the inhibitory action 
of caldesmon. This reversal was not complete and re- 
qured addition of a large excess of Ca-binding proteins. 
The effectivity of reversal decreased in the order S-100 
protein > troponin C = calmodulin. Three out of four 
preparations of calcimedins reversed the inhibitory ac- 
tion of caldesmon at lower concentration than other 
Ca-binding proteins. The effect of calcimedin was 
rather variable, was observed at the concentration of 
calcimedin close or equal to that of actin and was only 
slightly dependent on the presence of Ca2’. We failed to 
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detect any effect of calcimedin on the caldesmon-in- 
duced inhibition of acto-S-l ATPase activity. Since cal- 
cimedin did not interact with caldesmon and is unable 
to displace caldesmon from actin filaments we suppose 
that the observed effect of calcimedin on the actomyosin 
ATPase activity is non-specific and is due to crosslink- 
ing or bundling of actin filaments. 
4. DISCUSSION 
We analyzed the interaction of different Ca-binding 
proteins with caldesmon. In good agreement with ear- 
lier published data [21,22] we found that calmodulin can 
be crosslinked to caldesmon in the presence of Ca2’. 
Skeletal muscle troponin C can also be crosslink~ to 
caldesmon (see Fig. l), and troponin C and cahnodulin 
are approximately equal in reversal of caldesmon in- 
duced inhibition of actomyosin ATPase activity (Fig. 3). 
S-100 protein belonging to the same family of EF-hand 
Ca-binding proteins interacted with caldesmon, but un- 
like c~mod~in and troponin C we failed to crosslink 
S-100 to caldesmon. This may indicate that the sites of 
caldesmon interaction with S-100 protein are different 
from that of caldesmon-calmodulin interaction. In 
agreement with our earlier published data [4] we found 
that under certain conditions S-100 is more effective in 
reversal of caldesmon induced inhibition of skeletal ac- 
tomyosin ATPase than cahnodulin (Fig. 3). The effect 
of EF-hand proteins is explained by their direct interac- 
tion with caldesmon and their ability to cause partial 
detachment of caldesmon from actin-tropomyosin com- 
plex. 
67 kDa calcimedin belongs to another family of Ca- 
binding proteins called annexins. The 67 kDa calci- 
medin did not interact with isolated caldesmon (Fig. 1). 
In the presence of Ca*+ calcimedin interacted with actin- 
tropomyosin complex and about 0.5 mol of calcimedin 
were bound per mol of actin. These data are similar to 
those described for lip~ortin-85 [23]. Unlike lipocortin- 
85, the affinity of 67 kDa to actin-tropomyosin complex 
was rather low (the apparent dissociation constant was 
about 5 PM). Affinity of caldesmon to actin-tro- 
pomyosin is at least 5 times higher than that of calci- 
medin therefore under conditions used calcimedin did 
not compete with caldesmon for actin-tropomyosin 
binding (Fig. 2A), whereas addition of large quantities. 
of caldesmon displaced calcimedin from its complex 
with actin (Fig. 2B). Thus, calcimedin did not directly 
interact with caldesmon and was not able to displace 
caldesmon from its complex with actin-tro~myos~. 
Nevertheless, some preparations of calcimedin reversed 
the inhibitory action of caldesmon at lower concentra- 
tion than any other Ca-binding proteins (Fig. 3). The 
data presented do not mean that calcimedin is a more 
effective regulator of caldesmon action than calmod- 
ulin. The reversal of inhibition was observed when the 
concentration of calcimedin was close or equal to that 
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of actin. Under these conditions lipocortin-85 [23] and 
other annexins [24] can crosslink and bundle actin lila- 
ments. Therefore we may suppose that the effect ob- 
served is at least partly due to the change in the state 
of actin filaments. This suggestion correlates with the 
observation that calcimedin was ineffective in reversal 
of caldesmon-induced inhibition of acto-S-l ATPase ac- 
tivity. In this respect he effect of calcimedin is compara- 
ble with that of filamin which activated actomyosin 
ATPase activity but was unable to activate a&o-S-l 
ATPase activity 1251. It is worthwhile mentioning that 
after DEAE-Toyopearl chromatography calcimedin 
contained rather a large quantity of filamin and al- 
though gel-atration on Ultrogel AcA-44 column was 
very effective it is difIicult completely exclude contami- 
nation of filamin. Our preliminary data indicate that 
even at the molar ratio actin: filamin of 100: 1, filamin 
prevents the inhibitory action of caldesmon on the 
ATPase of actomyosin. Therefore even 1% contamina- 
tion of calcimedin by filamin will cause rather a strong 
effect on the ATPase activity under the conditions used 
(see Fig. 3). At present it is diffucult to explain the 
mechanism by which aggregation of actin filaments pre- 
vent the inhibitory action of caldesmon. In any case it 
is well-known that cross-linking of actin filaments 
strongly affects actin-myosin interaction and acto- 
myosin ATPase [25-27l. 
The data presented together with a low content of 67 
kDa calcimedin in smooth muscle cell [IS] and its pref- 
erential localization close to sarcolemma and other 
membranes of the cell [28} make the direct involvement 
of calcimedin in the regulation of contraction very im- 
probable. On the other hand we cannot completely ex- 
clude the effect of caicimedin (or other annexins pos- 
sessing higher affinity to actin) on caldesmon action in 
certain cell compartments which are enriched in Ca- 
phopholipid binding proteins. 
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